|
Oncogenes and Tumor Suppressors
Citations 21-30 of 795 total displayed.
|
Past content
(since May 2000):
|
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications
- Susan P. Whitman, Amy S. Ruppert, Michael D. Radmacher, Krzysztof Mrózek, Peter Paschka, Christian Langer, Claudia D. Baldus, Jing Wen, Frederick Racke, Bayard L. Powell, Jonathan E. Kolitz, Richard A. Larson, Michael A. Caligiuri, Guido Marcucci, and Clara D. Bloomfield
Blood 2008; 111: 1552-1559.
[Abstract]
[Full text]
[PDF]
Quantitative expression profiling guided by common retroviral insertion sites reveals novel and cell type–specific cancer genes in leukemia
- Martin Sauvageau, Michelle Miller, Sébastien Lemieux, Julie Lessard, Josée Hébert, and Guy Sauvageau
Blood 2008; 111: 790-799.
[Abstract]
[Full text]
[PDF]
A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling
- Katherine Bessette, Mark L. Lang, Roy A. Fava, Martin Grundy, Jennifer Heinen, Laurie Horne, Rosanne Spolski, Amin Al-Shami, Herbert C. Morse, III, Warren J. Leonard, and John A. Kelly
Blood 2008; 111: 344-350.
[Abstract]
[Full text]
[PDF]
NOTCH1 mutation can be an early, prenatal genetic event in T-ALL
- Minenori Eguchi-Ishimae, Mariko Eguchi, Helena Kempski, and Mel Greaves
Blood 2008; 111: 376-378.
[Abstract]
[Full text]
[PDF]
t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)
- Lisa J. Russell, Takashi Akasaka, Aneela Majid, Kei-ji Sugimoto, E. Loraine Karran, Inga Nagel, Lana Harder, Alexander Claviez, Stefan Gesk, Anthony V. Moorman, Fiona Ross, Helen Mazzullo, Jonathan C. Strefford, Reiner Siebert, Martin J. S. Dyer, and Christine J. Harrison
Blood 2008; 111: 387-391.
[Abstract]
[Full text]
[PDF]
A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification
- Dorothee Mueller, Christian Bach, Deniz Zeisig, Maria-Paz Garcia-Cuellar, Sara Monroe, Arun Sreekumar, Rong Zhou, Alexey Nesvizhskii, Arul Chinnaiyan, Jay L. Hess, and Robert K. Slany
Blood 2007; 110: 4445-4454.
[Abstract]
[Full text]
[PDF]
Uniform sensitivity of FLT3 activation loop mutants to the tyrosine kinase inhibitor midostaurin
- Elly V. Barry, Jennifer J. Clark, Jan Cools, Johannes Roesel, and D. Gary Gilliland
Blood 2007; 110: 4476-4479.
[Abstract]
[Full text]
[PDF]
Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors
- Jorge Cortes, Elias Jabbour, Hagop Kantarjian, C. Cameron Yin, Jianqin Shan, Susan O'Brien, Guillermo Garcia-Manero, Francis Giles, Megan Breeden, Nubia Reeves, William G. Wierda, and Dan Jones
Blood 2007; 110: 4005-4011.
[Abstract]
[Full text]
[PDF]
CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential
- Silvia Deaglio, Tiziana Vaisitti, Semra Aydin, Luciana Bergui, Giovanni D'Arena, Lisa Bonello, Paola Omedé, Maria Scatolini, Ozren Jaksic, Giovanna Chiorino, Dimitar Efremov, and Fabio Malavasi
Blood 2007; 110: 4012-4021.
[Abstract]
[Full text]
[PDF]
JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis
- Giovanni Barosi, Gaetano Bergamaschi, Monia Marchetti, Alessandro M. Vannucchi, Paola Guglielmelli, Elisabetta Antonioli, Margherita Massa, Vittorio Rosti, Rita Campanelli, Laura Villani, Gianluca Viarengo, Elisabetta Gattoni, Giancarla Gerli, Giorgina Specchia, Carmine Tinelli, Alessandro Rambaldi, and Tiziano Barbui, for the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Italian Registry of Myelofibrosis
Blood 2007; 110: 4030-4036.
[Abstract]
[Full text]
[PDF]
|
|
